Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moleculin Biotech (MBRX) Goodwill & Intangibles (2016 - 2025)

Moleculin Biotech (MBRX) has 10 years of Goodwill & Intangibles data on record, last reported at $11.1 million in Q3 2025.

  • For Q3 2025, Goodwill & Intangibles changed 0.0% year-over-year to $11.1 million; the TTM value through Sep 2025 reached $11.1 million, changed 0.0%, while the annual FY2024 figure was $11.1 million, 0.0% changed from the prior year.
  • Goodwill & Intangibles reached $11.1 million in Q3 2025 per MBRX's latest filing, roughly flat from $11.1 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $11.1 million in Q1 2021 and bottomed at $11.1 million in Q1 2021.
  • Average Goodwill & Intangibles over 5 years is $11.1 million, with a median of $11.1 million recorded in 2021.
  • The widest YoY moves for Goodwill & Intangibles: up 0.0% in 2021, down 0.0% in 2021.
  • A 5-year view of Goodwill & Intangibles shows it stood at $11.1 million in 2021, then changed by 0.0% to $11.1 million in 2022, then changed by 0.0% to $11.1 million in 2023, then changed by 0.0% to $11.1 million in 2024, then changed by 0.0% to $11.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $11.1 million in Q3 2025, $11.1 million in Q2 2025, and $11.1 million in Q1 2025.